Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC

Conditions

• Advanced Gastric Cancer
• Advanced Gastroesophageal Junction Adenocarcinoma

Interventions

• DRUG: PD-1 inhibitor(Tislelizumab) ,SOX(S-1+ Oxaliplatin)

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology